Works by Palumbo, Antonio


Results: 225
    1

    The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.

    Published in:
    Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303
    By:
    • Caers, Jo;
    • Fernández de Larrea, Carlos;
    • Leleu, Xavier;
    • Heusschen, Roy;
    • Zojer, Niklas;
    • Decaux, Olivier;
    • Kastritis, Efstathios;
    • Minnema, Monique;
    • Jurczyszyn, Artur;
    • Beguin, Yves;
    • Wäsch, Ralph;
    • Palumbo, Antonio;
    • Dimopoulos, Meletios;
    • Mateos, Maria Victoria;
    • Ludwig, Heinz;
    • Engelhardt, Monika
    Publication type:
    Article
    2

    Extra Virgin Olive Oil Polyphenol-Enriched Extracts Exert Antioxidant and Anti-Inflammatory Effects on Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.

    Published in:
    Antioxidants, 2025, v. 14, n. 2, p. 171, doi. 10.3390/antiox14020171
    By:
    • Tamburini, Bartolo;
    • Di Liberto, Diana;
    • Pratelli, Giovanni;
    • Rizzo, Chiara;
    • Barbera, Lidia La;
    • Lauricella, Marianna;
    • Carlisi, Daniela;
    • Maggio, Antonella;
    • Palumbo Piccionello, Antonio;
    • D'Anneo, Antonella;
    • Caccamo, Nadia;
    • Guggino, Giuliana
    Publication type:
    Article
    3

    Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 1, p. 23, doi. 10.1111/j.1600-0609.2010.01533.x
    By:
    • Dimopoulos, Meletios A.;
    • Mateos, Maria-Victoria;
    • Richardson, Paul G.;
    • Schlag, Rudolf;
    • Khuageva, Nuriet K.;
    • Shpilberg, Ofer;
    • Kropff, Martin;
    • Spicka, Ivan;
    • Palumbo, Antonio;
    • Wu, Ka Lung;
    • Esseltine, Dixie-Lee;
    • Liu, Kevin;
    • Deraedt, William;
    • Cakana, Andrew;
    • Van De Velde, Helgi;
    • San Miguel, Jesús F.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    High Mobility Group A proteins in esophageal carcinomas.

    Published in:
    Cell Cycle, 2016, v. 15, n. 18, p. 2410, doi. 10.1080/15384101.2016.1215388
    By:
    • Palumbo Júnior, Antonio;
    • Da Costa, Nathalia Meireles;
    • Esposito, Francesco;
    • Fusco, Alfredo;
    • Pinto, Luis Felipe Ribeiro
    Publication type:
    Article
    14
    15

    The Use of Middle Latency Auditory Evoked Potentials (MLAEP) as Methodology for Evaluating Sedation Level in Propofol-Drug Induced Sleep Endoscopy (DISE) Procedure.

    Published in:
    International Journal of Environmental Research & Public Health, 2021, v. 18, n. 4, p. 2070, doi. 10.3390/ijerph18042070
    By:
    • Arigliani, Michele;
    • Toraldo, Domenico M.;
    • Ciavolino, Enrico;
    • Lattante, Caterina;
    • Conte, Luana;
    • Arima, Serena;
    • Arigliani, Caterina;
    • Palumbo, Antonio;
    • De Benedetto, Michele;
    • Tchounwou, Paul B.
    Publication type:
    Article
    16
    17
    18
    19

    Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 3, p. 244, doi. 10.1002/ajh.24621
    By:
    • Gentile, Massimo;
    • Magarotto, Valeria;
    • Offidani, Massimo;
    • Musto, Pellegrino;
    • Bringhen, Sara;
    • Teresa Petrucci, Maria;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Uccello, Giuseppina;
    • Petrungaro, Annamaria;
    • Vigna, Ernesto;
    • Greco, Rosa;
    • Grazia Recchia, Anna;
    • Tripepi, Giovanni;
    • Ria, Roberto;
    • Di Raimondo, Francesco;
    • Palumbo, Antonio;
    • Morabito, Fortunato
    Publication type:
    Article
    20
    21
    22

    Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1085, doi. 10.1002/ajh.23835
    By:
    • Tacchetti, Paola;
    • Terragna, Carolina;
    • Galli, Monica;
    • Zamagni, Elena;
    • Petrucci, Maria Teresa;
    • Pezzi, Annalisa;
    • Montefusco, Vittorio;
    • Martello, Marina;
    • Tosi, Patrizia;
    • Baldini, Luca;
    • Peccatori, Jacopo;
    • Ruggieri, Miriana;
    • Pantani, Lucia;
    • Lazzaro, Antonio;
    • Elice, Francesca;
    • Rocchi, Serena;
    • Gozzetti, Alessandro;
    • Cavaletti, Guido;
    • Palumbo, Antonio;
    • Cavo, Michele
    Publication type:
    Article
    23
    24
    25

    European Perspective on Multiple Myeloma Treatment Strategies in 2014.

    Published in:
    2014
    By:
    • Ludwig, Heinz;
    • Sonneveld, Pieter;
    • Davies, Faith;
    • Bladé, Joan;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • Morgan, Gareth;
    • de la Rubia, Javier;
    • Delforge, Michel;
    • Dimopoulos, Meletios;
    • Einsele, Hermann;
    • Facon, Thierry;
    • Goldschmidt, Hartmut;
    • Moreau, Philippe;
    • Nahi, Hareth;
    • Plesner, Torben;
    • San-Miguel, Jesús;
    • Hajek, Roman;
    • Sondergeld, Pia;
    • Palumbo, Antonio
    Publication type:
    Journal Article
    26

    European Perspective on Multiple Myeloma Treatment Strategies in 2014.

    Published in:
    Oncologist, 2014, v. 19, n. 8, p. 829, doi. 10.1634/theoncologist.2014-0042
    By:
    • Ludwig, Heinz;
    • Sonneveld, Pieter;
    • Davies, Faith;
    • Bladé, Joan;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • Morgan, Gareth;
    • Rubia, Javier;
    • Delforge, Michel;
    • Dimopoulos, Meletios;
    • Einsele, Hermann;
    • Facon, Thierry;
    • Goldschmidt, Hartmut;
    • Moreau, Philippe;
    • Nahi, Hareth;
    • Plesner, Torben;
    • San‐Miguel, Jesús;
    • Hajek, Roman;
    • Sondergeld, Pia;
    • Palumbo, Antonio
    Publication type:
    Article
    27

    Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective.

    Published in:
    Oncologist, 2010, v. 15, n. 1, p. 6, doi. 10.1634/theoncologist.2009-0203
    By:
    • LUDWIG, HEINZ;
    • BEKSAC, MERAL;
    • BLADÉ, JOAN;
    • BOCCADORO, MARIO;
    • CAVENAGH, JAMIE;
    • CAVO, MICHELE;
    • DIMOPOULOS, MELETIOS;
    • DRACH, JOHANNES;
    • EINSELE, HERMANN;
    • FACON, THIERRY;
    • GOLDSCHMIDT, HARTMUT;
    • HAROUSSEAU, JEAN-LUC;
    • HESS, URS;
    • KETTERER, NICOLAS;
    • KROPFF, MARTIN;
    • MENDELEEVA, LARISA;
    • MORGAN, GARETH;
    • PALUMBO, ANTONIO;
    • PLESNER, TORBEN;
    • MIGUEL, JESÚS SAN
    Publication type:
    Article
    28
    29

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    30
    31
    32
    33

    Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    34

    Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    35
    36

    Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 9, p. 1722, doi. 10.3109/10428194.2012.664844
    By:
    • Offidani, Massimo;
    • Polloni, Claudia;
    • Cavallo, Federica;
    • Marina Liberati, Anna;
    • Ballanti, Stelvio;
    • Pulini, Stefano;
    • Catarini, Massimo;
    • Alesiani, Francesco;
    • Corvatta, Laura;
    • Gentili, Silvia;
    • Caraffa, Patrizia;
    • Boccadoro, Mario;
    • Leoni, Pietro;
    • Palumbo, Antonio
    Publication type:
    Article
    37

    MyelomA Genetics International Consortium.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 796, doi. 10.3109/10428194.2011.639881
    By:
    • Morgan, Gareth;
    • Johnsen, Hans Erik;
    • Goldschmidt, Hartmut;
    • Palumbo, Antonio;
    • Cavo, Michele;
    • Sonneveld, Pieter;
    • Miguel, Jesus San;
    • Chim, Char Sang;
    • Browne, Paul;
    • Einsele, Hermann;
    • Waage, Anders;
    • Turesson, Ingemar;
    • Spencer, Andrew;
    • Hajek, Roman;
    • Ludwig, Heinz;
    • Hemminki, Kari;
    • Houlston, Richard
    Publication type:
    Article
    38
    39

    Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1444, doi. 10.3109/10428194.2010.486878
    By:
    • Offidani, Massimo;
    • Leoni, Pietro;
    • Bringhen, Sara;
    • Corvatta, Laura;
    • Larocca, Alessandra;
    • Gentili, Silvia;
    • Oliva, Stefania;
    • Polloni, Claudia;
    • Galieni, Piero;
    • Catarini, Massimo;
    • Alesiani, Francesco;
    • Mele, Anna;
    • Brunori, Marino;
    • Blasi, Nicola;
    • Ferranti, Mario;
    • Visani, Giuseppe;
    • Boccadoro, Mario;
    • Palumbo, Antonio
    Publication type:
    Article
    40
    41
    42
    43

    Interferon-γ in Multiple Myeloma.

    Published in:
    Leukemia & Lymphoma, 1995, v. 18, n. 3/4, p. 215, doi. 10.3109/10428199509059610
    By:
    • Palumbo, Antonio;
    • Bruno, Benedetto;
    • Boccadoro, Mario;
    • Pileri, Alessandro
    Publication type:
    Article
    44
    45

    Hsp60 chaperonopathies and chaperonotherapy: targets and agents.

    Published in:
    Expert Opinion on Therapeutic Targets, 2014, v. 18, n. 2, p. 185, doi. 10.1517/14728222.2014.856417
    By:
    • Cappello, Francesco;
    • Marino Gammazza, Antonella;
    • Palumbo Piccionello, Antonio;
    • Campanella, Claudia;
    • Pace, Andrea;
    • Conway de Macario, Everly;
    • Macario, Alberto JL
    Publication type:
    Article
    46
    47
    48
    49
    50